{"id":"https://openalex.org/W640279122","doi":null,"title":"Textbook of pharmacotherapy for child and adolescent psychiatric disorders","display_name":"Textbook of pharmacotherapy for child and adolescent psychiatric disorders","publication_year":1994,"publication_date":"1994-01-01","ids":{"openalex":"https://openalex.org/W640279122","mag":"640279122"},"language":"en","primary_location":{"id":"mag:640279122","doi":null,"is_oa":false,"landing_page_url":"http://ci.nii.ac.jp/ncid/BA27891969","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101542362","display_name":"David Rosenberg","orcid":"https://orcid.org/0000-0002-0911-0471","observed_orcids":["https://orcid.org/0000-0002-0911-0471"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Rosenberg","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0911-0471","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067047228","display_name":"John R. Holttum","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Holttum","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5019021504","display_name":"Samuel Gershon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samuel Gershon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.6341,"has_fulltext":false,"cited_by_count":38,"citation_normalized_percentile":{"value":0.89162983,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.3799000084400177,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.3799000084400177,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10182","display_name":"Child and Adolescent Psychosocial and Emotional Development","score":0.25540000200271606,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.2094999998807907,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/child-and-adolescent-psychopharmacology","display_name":"child and adolescent psychopharmacology","score":0.8379999995231628},{"id":"https://openalex.org/keywords/child-mental-disorders","display_name":"child psychopathology","score":0.5569999814033508},{"id":"https://openalex.org/keywords/psychostimulants","display_name":"psychostimulants","score":0.953000009059906},{"id":"https://openalex.org/keywords/tricyclic-antidepressants","display_name":"tricyclic antidepressants","score":0.972000002861023},{"id":"https://openalex.org/keywords/atypical-antidepressants","display_name":"atypical antidepressants","score":0.9810000061988831},{"id":"https://openalex.org/keywords/monoamine-oxidase-inhibitors","display_name":"monoamine oxidase inhibitors","score":0.9660000205039978},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.972000002861023},{"id":"https://openalex.org/keywords/lithium","display_name":"lithium","score":0.996999979019165},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.9959999918937683},{"id":"https://openalex.org/keywords/anxiolytics","display_name":"anxiolytics","score":0.9980000257492065},{"id":"https://openalex.org/keywords/adrenergic-agents","display_name":"adrenergic agents","score":0.9850000143051147},{"id":"https://openalex.org/keywords/substance-use-disorders","display_name":"substance use disorders","score":0.7860000133514404},{"id":"https://openalex.org/keywords/psychosomatic-medicine","display_name":"psychosomatic medicine","score":0.7620000243186951}],"concepts":[{"id":"https://openalex.org/C103709681","wikidata":"https://www.wikidata.org/wiki/Q1515727","display_name":"Psychopharmacology","level":2,"score":0.7682160139083862},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.7167143821716309},{"id":"https://openalex.org/C2781081902","wikidata":"https://www.wikidata.org/wiki/Q3539074","display_name":"Tricyclic","level":2,"score":0.6894552707672119},{"id":"https://openalex.org/C557119937","wikidata":"https://www.wikidata.org/wiki/Q1741745","display_name":"Child and adolescent psychiatry","level":2,"score":0.5699760913848877},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.48082101345062256},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4797707498073578},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.42117026448249817},{"id":"https://openalex.org/C2778541603","wikidata":"https://www.wikidata.org/wiki/Q152763","display_name":"Lithium (medication)","level":2,"score":0.41123831272125244},{"id":"https://openalex.org/C542102704","wikidata":"https://www.wikidata.org/wiki/Q183257","display_name":"Psychotherapist","level":1,"score":0.34037643671035767},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.22710135579109192},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2038605809211731}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:640279122","doi":null,"is_oa":false,"landing_page_url":"http://ci.nii.ac.jp/ncid/BA27891969","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W6995935984","https://openalex.org/W583491472","https://openalex.org/W2808750309","https://openalex.org/W4230396949","https://openalex.org/W2027834828","https://openalex.org/W2075764641","https://openalex.org/W7133701900","https://openalex.org/W4226022149","https://openalex.org/W2979420901","https://openalex.org/W2956548523"],"abstract_inverted_index":{"Introduction":[0],"to":[1],"Psychopharmacology.":[2,9],"Historical":[3],"Perspective":[4],"on":[5],"Child":[6,38],"and":[7,39,43],"Adolescent":[8,40],"Characteristics":[10],"of":[11,19,53],"Drug":[12],"Disposition":[13],"in":[14,37],"Childhood.":[15],"Part":[16],"II:":[17],"Classes":[18],"Medication:":[20],"Psychostimulants.":[21],"Tricyclic":[22],"Antidepressants.":[23,26],"Novel":[24],"(Atypical)":[25],"Monoamine":[27],"Oxidose":[28],"Inhibitors.":[29],"Antipsychotic":[30],"Agents.":[31,45],"Lithium.":[32],"Anticonvulsants.":[33],"Anxiolytics.":[34],"Adrenergic":[35],"Agents":[36],"Psychiatry.":[41,48],"Atypical":[42],"Adjunctive":[44],"Consultation.":[46],"Liaison":[47],"Pharmacologic":[49],"Approaches.":[50],"Pharmacological":[51],"Treatment":[52],"Substance":[54],"Abuse":[55],"Disorders.":[56]},"counts_by_year":[],"updated_date":"2026-10-25T09:29:13.331239","created_date":"2016-06-24T00:00:00"}